New software platform improves freeze drying process control

16 Jan 2019

The LyoS 2.0 control system software is fully configurable and fully validatable for regulated pharmaceutical and biotechnology applications.

SP Scientific has launched LyoS 2.0 – a line-of-sight enabled lyophilizer control system able to control platforms from development to production units, making cycle transfer and scale-up much simpler.

New software platform improves freeze drying process control

The LyoS 2.0 control system delivers unmatched process control for all stages of the cycle, from freezing to primary and secondary drying. User definable process alarms protect the user's valuable product and automated system tests to ensure the lyophilizer is running optimally.

In addition, the control system is designed to control proprietary SP Scientific freeze drying technologies including ControLyo ice nucleation, SMART automatic cycle development and LyoFlux TDLAS continuous process monitoring.

Optional 21 CFR Part 11 compliance capabilities ensure that LyoS 2.0 control system software is both fully configurable and fully validatable for regulated pharmaceutical and biotechnology applications. SP Scientific offers testing protocols intended to support the processes that will be performed by the purchaser and/or end user, as well as onsite control system IQ/OQ validation support and a comprehensive factory-initiated software validation.

Designed for SP Scientific's research, development, and production lyophilizers, including the LyoCapsule, LyoStar, Genesis, Ultra and LyoConstellation. LyoS 2.0 and SP Line of Sight technologies can be upgraded on to certain other freeze dryers.

Read More

Related news

Pharmapack Europe 2019 Award Winners

Pharmapack Europe 2019 Award Winners

7 Feb 2019

Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.

Read more 
Brexit - the EU FMD's painful problem

Brexit - the EU FMD's painful problem

7 Feb 2019

Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.

Read more 
New series of advanced freeze dryers

New series of advanced freeze dryers

6 Feb 2019

The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.

Read more 
Hitachi Chemical to acquire apceth Biopharma

Hitachi Chemical to acquire apceth Biopharma

5 Feb 2019

Acquisition will strengthen Hitachi's presence in the second-largest cell and gene therapy market in the world.

Read more 
FDA approves first generic Advair Diskus

FDA approves first generic Advair Diskus

4 Feb 2019

Mylan's Wixela Inhub is the first FDA-approved therapeutically equivalent generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or COPD.

Read more 
Sartorius joins the community of the National Institute for Innovation in Manufacturing Biopharmaceuticals

Sartorius joins the community of the National Institute for Innovation in Manufacturing Biopharmaceuticals

3 Feb 2019

Company hopes to contribute substantially to further optimizing and accelerating the current manufacturing processes in the biopharmaceutical industry.

Read more 
Particle Sciences partners with Encube Ethicals to develop novel vaginal rings

Particle Sciences partners with Encube Ethicals to develop novel vaginal rings

31 Jan 2019

The partnership will focus on rings for the administration of existing approved drugs, improving drug effectiveness and patient compliance.

Read more 
Manufacturing consultancy up 150% as life sciences prepare for a digital future

Manufacturing consultancy up 150% as life sciences prepare for a digital future

30 Jan 2019

Increasing appetite for digitised manufacturing and using data to improve GMP manufacturing.

Read more 
SGS expands testing capabilities at its Glasgow facility

SGS expands testing capabilities at its Glasgow facility

29 Jan 2019

Clients will benefit from a fully comprehensive range of validated biosafety methods to support cell bank and viral vaccine manufacturing and lot release of drug product.

Read more 
UK and Russia sign MoU on regulatory co-operation on medicines

UK and Russia sign MoU on regulatory co-operation on medicines

29 Jan 2019

Medicines regulators of the UK and Russian set out key principles to support their collaboration on improving public health.

Read more